Hudson Institute of Medical Research
About
Hudson Institute of Medical Research is an Australian translational medical research institute focused on advancing discovery science and clinical applications in inflammation, cancer, and women's and newborn health. Located at Monash Health Translation Precinct in Victoria, the institute conducts research into chronic inflammatory diseases, infectious diseases, and cancer, with a mission to develop new diagnostic and treatment approaches for conditions affecting millions globally.
Tips for Applicants
Prospective partners should align research proposals with Hudson's core focus areas of inflammation, cancer, or women's and newborn health, and demonstrate translational potential from bench to clinical application. Researchers should consider the institute's emphasis on addressing globally significant health burdens and under-diagnosed conditions.
Giving Philosophy
Hudson Institute supports translational medical research that bridges discovery science with clinical application, prioritizing areas where chronic inflammation and cancer significantly impact human health. The institute appears to value innovative approaches to diagnosis and treatment development, with emphasis on conditions that are either under-diagnosed or represent major global health burdens.
ACNC Financial History
| Year | Grants Given | Revenue | Total Assets | Net Assets |
|---|---|---|---|---|
| FY2023 | — | $64.3M | $53.5M | $25.3M |
| FY2022 | $3.0M | $58.3M | $50.9M | $23.5M |
| FY2021 | $2.1M | $58.9M | $50.7M | $23.3M |
| FY2020 | — | $53.9M | $42.0M | $21.1M |
| FY2019 | — | $49.4M | $35.8M | $17.3M |
| FY2018 | — | $47.7M | $31.0M | $16.2M |
| FY2017 | — | $42.8M | $30.1M | $16.6M |
| 7yr total | $5.0M | Source: ACNC Annual Information Statements | ||